Next Article in Journal
Exploring a Bioequivalence Failure for Silodosin Products Due to Disintegrant Excipients
Next Article in Special Issue
Extracellular Vesicle-Based Therapeutics in Neurological Disorders
Previous Article in Journal
In Silico Drug Repurposing Framework Predicts Repaglinide, Agomelatine and Protokylol as TRPV1 Modulators with Analgesic Activity
Previous Article in Special Issue
Phospholipid-Membrane-Based Nanovesicles Acting as Vaccines for Tumor Immunotherapy: Classification, Mechanisms and Applications
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(12), 2564; https://doi.org/10.3390/pharmaceutics14122564
Action Date Notes Link
article xml file uploaded 23 November 2022 05:05 CET Original file -
article xml uploaded. 23 November 2022 05:05 CET Update https://www.mdpi.com/1999-4923/14/12/2564/xml
article pdf uploaded. 23 November 2022 05:05 CET Version of Record https://www.mdpi.com/1999-4923/14/12/2564/pdf
article supplementary file uploaded. 23 November 2022 05:05 CET - https://www.mdpi.com/1999-4923/14/12/2564#supplementary
article html file updated 23 November 2022 05:07 CET Original file -
article html file updated 1 March 2023 00:23 CET Update -
article html file updated 3 March 2023 22:07 CET Update https://www.mdpi.com/1999-4923/14/12/2564/html
Back to TopTop